ARCHIVES

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

New CREGs Announced In Epidemiology, Viruses, Carcinogenesis

April 23, 1976

NCI Cooperative Group, Cancer Center Trials Listed

June 29, 2007

FDA Staff Failed To Explain Approval Standards, Correct Misconceptions.

April 13, 2007

Case Western Wins Renewal.

October 5, 2001

Becker, Jako, Epstein Wrangle Over Basic Research, ‘Cancer Establishment’

May 15, 1992

NCI Issues Statement On Endostatin Research

October 1, 1999